Download PDF
Thromb Haemost 1974; 32(02/03): 247-259
DOI: 10.1055/s-0038-1647695
Original Article
Schattauer GmbH

Erythrocytes and Blood Coagulation

Douglas MacN. Surgenor
1   School of Medicine State University of New York at Buffalo Buffalo, New York 14214
› Author Affiliations
Further Information

Publication History

Received 29 April 1974

Accepted 04 July 1974

Publication Date:
30 June 2018 (online)

    Permissions and Reprints

Summary

The action of intact and hemolyzed red cells in in vitro clotting systems is analyzed against the background of the clinical manifestations of red cell procoagulants in incompatible transfusions and hemolytic anemias in man and in experimental animals. It is suggested that the nature of the lesion in the stroma may be of importance in determining the biological effects.

 

  • References

  • 1 Ambrus J. L, Ambeus C. M, Munson A. 1969. Model systems for the study of thrombosis. In: Johnson S. A, Guest M. M. (eds.), Dynamics of Thrombus Formation and Dissolution. Lippincott Philadelphia: Pennsylvania; 182.
    Google Scholar
  • 2 Ashkinazi IYa. 1969; Effect of adrenalin on ability of intact erythrocytes to increase plasma thromboplastin activity. Bulletin of Experimental Biology and Medicine (U.S.S.R.) 67: 1.
    CrossrefPubMedGoogle Scholar
  • 3 Astrowe P. S. 1922; Hemolysis following transfusion. Journal of the American Medical Association 79: 1511.
    CrossrefPubMedGoogle Scholar
  • 4 Barratt J. O.W. 1913; On fibrinaemia. Journal of Pathology and Bacteriology 17: 303.
    PubMedGoogle Scholar
  • 5 Barratt J. O.W, Yorke W. 1914; The production of general symptoms in haemoglobenaemia. British Medical Journal 06: 235.
    PubMedGoogle Scholar
  • 6 Bentley Jr. H. P, Krivit W. 1960; An assay of antihemophilic globulin activity in the carrier female. Journal of Laboratory and Clinical Medicine 56: 613.
    PubMedGoogle Scholar
  • 7 Biggs R, Douglas A. S, MacFarlane R. G. 1953; The formation of thromboplastin in human blood. Journal of Physiology 119: 89.
    CrossrefPubMedGoogle Scholar
  • 8 Biggs R, Denson K. W.E, Riesenberg D, McIntyre C. 1968; The coagulant activity of platelets. British Journal of Haematology 15: 283.
    CrossrefPubMedGoogle Scholar
  • 9 Birndorf N. I, Lopas H. 1970; Intravascular coagulation in cynomologus monkeys produced by red blood cell stroma. Clinical Research 18: 398.
    PubMedGoogle Scholar
  • 10 Bradlow E. A. 1961; Liberation of material with platelet-like coagulant properties from intact red cells and particularly from reticulocytes. British Journal of Haematology 07: 476.
    CrossrefPubMedGoogle Scholar
  • 11 Brown D. L. 1970; Acute complement-mediated haemolysis in the rabbit. British Journal of Haematology 19: 499.
    CrossrefPubMedGoogle Scholar
  • 12 Cochin A, Dewoskin R, Moss G. S. 1972. Stroma free solution Correction of anticoagulant properties. Proceedings of the Third Congress of the International Society of Thrombosis and Haemostasis. Washington, D.C: (Abstract).
    Google Scholar
  • 13 Crosby W. H, Stefanini M. 1952; Pathogenesis of the plasma transfusion reaction with especial reference to the blood coagulation system. Journal of Laboratory and Clinical Medicine 40: 374.
    PubMedGoogle Scholar
  • 14 Dodge J. T, Mitchell C, Hanahan D. J. 1963; The preparation and chemical characteristics of hemoglobin-free ghosts of human erythrocytes. Archives of Biochemistry and Biophysics 100: 119.
    CrossrefPubMedGoogle Scholar
  • 15 Evensen S. A, Jeremic M. 1970; Platelets and the triggering mechanism of intra-vascular coagulation. British Journal of Haematology 19: 33.
    CrossrefPubMedGoogle Scholar
  • 16 Garatun-Tjeldsto E, Krüger K. S. 1971; Age dependent variation in coagulation properties and heparin response of human blood hemolysate and plasma. Experimental Gerontology 06: 125.
    CrossrefPubMedGoogle Scholar
  • 17 Gavras H. et al. 1971; Microangiopathic hemolytic anemia and the development of the malignant phase of hypertension. Circulation Research, Suppl. II, 28 29: 127.
    PubMedGoogle Scholar
  • 18 Georgatsos J. C, Hussey C. V, Quick A. J. 1955; Nature and action of a new clotting factor obtained from erythrocytes. American Journal of Physiology 181: 30.
    PubMedGoogle Scholar
  • 19 Hamilton P. B, Farr L. E, Hiller A, Van Slyke D. D. 1947; Preparation of hemoglobin solutions for intra-venous infusion. Journal of Experimental Medicine 84: 455.
    PubMedGoogle Scholar
  • 20 Hoffman J. G. 1958; Physiological characteristics of human red blood cell ghosts. Journal of General Physiology 42: 9.
    CrossrefPubMedGoogle Scholar
  • 21 Hussey C. V, Kaser M. M. 1956; Erythrocytin, a clotting factor from erythrocytes: Its action and purification. Federation Proceedings 15: 279.
    PubMedGoogle Scholar
  • 22 Jansarik H, Koppler E, Lasch M. G. 1972; Experimentelle Immunhämolyse und Blutgerinnung. Thrombosis et Diathesis Haemorrhagica 26: 22.
    PubMedGoogle Scholar
  • 23 Krasik Y. D, Abdulkadyrov K. M. 1971; Blood coagulation and the role of erythrocytes in the process of haemostasis in hypoplastic anemia. Gemat. Pereli. Krovi 16: 35.
    PubMedGoogle Scholar
  • 24 Krevans J. R, Jackson D. P, Conley C. L, Hartman B. C. 1957; The nature of the hemorrhagic disorder accompanying hemolytic transfusion reactions in man. Blood 12: 834.
    PubMedGoogle Scholar
  • 25 Lasch H. G, Heene D. L. 1967; Diagnosis of intravascular coagulation and fibrinolysis. Thrombosis et Diathesis Haemorrhagica, Suppl 26: 351.
    PubMedGoogle Scholar
  • 26 Levine E. C, Segall H. N. 1922; Post transfusion reactions. Surgical Gynecology and Obstetrics 35: 313.
    PubMedGoogle Scholar
  • 27 Lopas H, Birndorf N. I. 1972; Hemolysis and intravascular coagulation due to incompatible red cell transfusion in isoimmunized monkeys. British Journal of Haematology 21: 399.
    PubMedGoogle Scholar
  • 28 Lopas H, Birndorf N. I, Robboy S. J. 1971; Experimental transfusion reactions and disseminated intravascular coagulation produced by incompatible plasma in monkeys. Transfusion 11: 196.
    CrossrefPubMedGoogle Scholar
  • 29 Lopas H, Birndorf N. I, Bell Jr. C. E, Robboy S. J, Fortwengler H. P, Biddison N. E. 1972; Haemolysis and intravascular coagulation due to incompatible red cells in isoimmunized monkeys. British Journal of Haematology 23: 765.
    CrossrefPubMedGoogle Scholar
  • 30 Lorie Y. I, Orlova L. D. 1964; Changes in clotting system in blood in Marchiafava-Micheli disease. Federation Proceeding Transactions, Suppl 23: 1226.
    PubMedGoogle Scholar
  • 31 Marcus A. J. 1966; The role of lipids in blood coagulation. Advances in Lipid Research 04: 1.
    PubMedGoogle Scholar
  • 32 McKay D. G, Hardaway R. M, Wahle G. H, Edelstein R, Tartock D. E. 1955; Alterations in blood coagulation mechanism after incompatible blood transfusion. American Journal of Surgery 89: 583.
    CrossrefPubMedGoogle Scholar
  • 33 McKellar M, Dacie J. V. 1958; Thromboplastic activity of the plasma in paroxysmal nocturnal haemoglobinuria. British Journal of Haematology 04: 404.
    CrossrefPubMedGoogle Scholar
  • 34 de Matteis F, Vulpis N. 1960; The influence of blood corpuscles on clot firmness: Thromboelastographic observations. Thrombosis et Diathesis Haemorrhagica 04: 71.
    PubMedGoogle Scholar
  • 35 Mey U, Hesse P. 1966; Über den Einfluß des erythrozytins auf die Blutgerinnung. Blut 13: 30.
    CrossrefPubMedGoogle Scholar
  • 36 O’Brien J. R. 1959; Some effects on blood coagulation of erythrocytes and other cells. Journal of Clinical Pathology 12: 45.
    CrossrefPubMedGoogle Scholar
  • 37 O’Brien J. R. 1961. In: Johnson S. A, Monto R. W, Rebuck J. W, Horn Jr. R. C. (eds.) Bloods Platelets. Little Brown; Boston, Massachusetts: 323.
  • 38 Quick A. J. 1957 Hemorrhagic Diseases Lea and Febiger Philadelphia Pennsylvania.
    PubMedGoogle Scholar
  • 39 Quick A. J, Hussey C. V. 1955; Erythrocytin, a new clotting factor from erythrocytes : Its value in the study of hemophilia. Journal of Laboratory and Clinical Medicine 46: 940.
    PubMedGoogle Scholar
  • 40 Quick A. J, Georgatsos J. G, Hussey C. V. 1954; The clotting activity of human erythrocytes: Theoretical and clinical implications. American Journal of Medical Sciences 228: 207.
    CrossrefPubMedGoogle Scholar
  • 41 Quick A. J, Hickey M. E. 1960; Influence of erythrocytes on the coagulation of blood. American Journal of Medical Sciences 239: 51.
    CrossrefPubMedGoogle Scholar
  • 42 Quick A. J, Hickey M. E. 1961; Hemolysate prothrombin consumption time: A new test for thromboplastinogenic coagulation defects. Journal of Laboratory and Clinical Medicine 57: 290.
    PubMedGoogle Scholar
  • 43 Quick A. J. 1966. Hemorrhagic Diseases and Thrombosis. Second edition,. Lea and Febiger, Philadelphia: Pennsylvania.;
    Google Scholar
  • 44 Quick A. J, Hussey C. V. 1956; Hemophilia: Quantitative studies of the coagulation defect. Archives of Internal Medicine 97: 524.
    CrossrefPubMedGoogle Scholar
  • 45 Rabiner S. F, Friedman L. H. 1968; The role of intravascular hemolysis and the reticuloendothelial system in the production of a hypercoagulable state. British Journal Haematology 14: 105.
    CrossrefPubMedGoogle Scholar
  • 46 Rabiner S. F, Helbert J. R, Lopas H, Friedman L. H. 1967; Evaluation of a stroma-free hemoglobin solution for use as a plasma expander. Journal of Experimental Medicine 126: 1127.
    CrossrefPubMedGoogle Scholar
  • 47 Redman C. M. 1971; Phospholipid metabolism in intact and modified erythrocyte membranes. Journal of Cell Biology 49: 35.
    CrossrefPubMedGoogle Scholar
  • 48 Redman C. M. 1972; Proteolipid involvement in human erythrocyte membrane function. Biochemica et Biophysica Acta 282: 123.
    CrossrefPubMedGoogle Scholar
  • 49 Rock R. C, Bove J. R, Nemerson Y. 1969; Heparin treatment of intravascular coagulation accompanying hemolytic transfusion reactions. Transfusion 09: 57.
    CrossrefPubMedGoogle Scholar
  • 50 Sachs J. R, Knauf P. A, Dunham P. B. 1974. Transport through red cell membranes. In: Surgenor DMacN. (ed.) The Bed Blood Cell. second edition,. Academic Press; New York.:
    Google Scholar
  • 51 Schmidt P. J, Holland P. V. 1967; Pathogenesis of the acute renal failure associated with incompatible transfusion. The Lancet 02: 1169.
    PubMedGoogle Scholar
  • 52 Scott R. B, Robb-Smith A. H.T, Scowen E. F. 1938; The Marchiaf-Micheli syndrome of nocturnal haemoglobinuria with haemolytic anemia. Quarterly Journal of Medicine 07: 95.
    PubMedGoogle Scholar
  • 53 Seldon T. H. 1949; Transfusion reactions among patients under general anesthesia. Mississippi Valley Medical Journal 71: 124.
    PubMedGoogle Scholar
  • 54 Semar M, Skoza L, Johnson A. J. 1969; Partial purification and properties of a plasminogen activator from human erythrocytes. Journal of Clinical Investigation 48: 1777.
    CrossrefPubMedGoogle Scholar
  • 55 Shinowara G. 1951; Enzyme studies on human blood. Journal of Laboratory and Clinical Medicine 38: 11.
    PubMedGoogle Scholar
  • 56 Shulman N. R, Weinrach R. S, Libre E. P, Andrews H. L. 1965; The role of the reticuloendothelial system in the pathogenesis of idiopathic thrombocytopenic purpura. Transaction of the Association of American Physicians 78: 374.
    PubMedGoogle Scholar
  • 57 Teorell T. 1952; Permeability properties of erythrocyte ghosts. Journal of General Physiology 35: 669.
    CrossrefPubMedGoogle Scholar
  • 58 Triantaphyllopoulos E. 1971; Hemoglobin, inhibitor of contact phase of blood coagulation. Life Sciences 10: 813.
    PubMedGoogle Scholar
  • 59 Triantaphyllopoulos E. 1972. Inhibition of plasminogen activation by hemoglobin. Proceedings of the Illrd Congress of the International Society of Thrombosis and Haemostasis. Washington D.C: August, 1972. 308 (abstract).
    Google Scholar
  • 60 Triantaphyllopoulos E. 1973; Effect of erythrocytes on coagulation and fibrinolysis: Pathogenesis of intravascular coagulation following intravascular hemolysis. Thrombosis et Diathesis Haemorrhagica, Suppl 53: 243.
    PubMedGoogle Scholar
  • 61 Troup S. B, Reed C. F, Marinetti G. Y, Swisher S. N. 1960; Thromboplastic factors in the platelets and red blood cells : Observations on their chemical nature and function in vitro coagulation. Journal of Clinical Investigation 39: 342.
    CrossrefPubMedGoogle Scholar
  • 62 Troup S. B, Reed C. F, Marinetti G. V, Swisher S. N. 1961. In: Johnson S. A, Monto R. W, Rebuck J. W, Horn Jr. R. C. (eds.), Blood ‘platelets. 289 Little Brown; Boston, Massachusetts.:
  • 63 Walther B. 1956; Über die Gerinnungsaktivität hämolysierter menschlicher Erythrozyten. Blut 02: 211.
    CrossrefPubMedGoogle Scholar
  • 64 Weber U, Schenck W, Kunzer W. 1971; Über den Einfluß intakter Erythrozyten auf verschiedene Gerinnungskriterien. Med. Welt 22: 1662.
    PubMedGoogle Scholar
  • 65 Weed R. I, Reed C. F, Berg G. 1963; Is Hemoglobin an Essential Structural Component of Human Erythrocyte Membranes. Journal of Clinical Investigations 42: 581.
    CrossrefPubMedGoogle Scholar
  • 66 Wooldridge L. (1886a): Note on the Relation of the Red Blood Corpuscles to Coagulation. Practitioner 38: 187.
    PubMedGoogle Scholar
  • 67 Wooldridge L. (1886b): Über Intravasculäre Gerinnungen. Archiv für Physiologie (Leipzig) 397.
    PubMedGoogle Scholar